TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Cerebrospinal fluid analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in facial indicators of sleepiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No. and severity of Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Vital signs, physical examination, clinical laboratory tests, ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety as measured by NCI CTCAE v 3.0
Endpoint domain: Adverse events/effects
Primary endpoint: Number, frequency, and severity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the curve (AUC) comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receiver operating characteristic (ROC) comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostate sector analysis based on Gleason score comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Perioperative major bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Stroke (fatal, non-fatal)
Endpoint domain: Mortality/survival
Primary endpoint: Success rate of VATS major pulmonary resection with SND
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of days for Calcium/Creatinine Clearance to normalize
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of actual ovarian cancer cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean change in blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean change in glycated hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in LDL-cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nicotine absorption profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Time from catheter removal to passing void trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: related adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting Local Reactogenicity Signs and Symptoms Within 7 Days
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting Systemic Reactogenicity Signs and Symptoms Within 7 Days
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With One or More Unsolicited Non-Serious Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: MII oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: fertilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: blastocysts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Failure of assisted hemodialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of Serious and Non-Serious Immune Mediated Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: MACE (Acute myocardial infarction, stroke, heart failure requiring hospitalisation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Transfusion improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum activity (Amax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the effect curve (AUEC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Post-operative Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Response Per Hidradenitis Suppurativa Clinical Response (HiSCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abscess and Inflammatory Nodule (AN) Count of 0, 1, or 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin Pain NRS30 - At Worst
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC[0-tau]) of GSK3640254
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of GSK3640254
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Remission Rate (CR/CRi)
Endpoint domain: Mortality/survival
Primary endpoint: Safety of CIML NK Cells as Measured by the Number of Participants With Treatment Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with serious infections, malignancies, and other serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Vein Diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Aneuploidy Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Plasma concentrations of TA-8995, midazolam and digoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of escalation of care due to treatment failure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Yolk sac morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Experienced Any Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Patient-Reported Breathing Difficulty
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of total reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of mean reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of numbers of omission and commission errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality of takotsubo syndrome
Endpoint domain: Mortality/survival
Primary endpoint: Morbidity of takotsubo syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Smell Identification Test Score at 6 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Smell Threshold Test Score at 6 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plaque index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Myocardial T2 relaxation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myocardial ECV measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myocardial strain analysis (focussed on longitudinal strain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain - Visual Analogue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Growth rate of small colorectal polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change of pain scores on the Visual Analogue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Plaque Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety levels in preschool children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of change from baseline in serum triglyceride level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adverse events after the start of study drug administration
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Time Rhythm Monitoring Compromised
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of Treatment Emergent Adverse Events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Adverse Events of Special Interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Columbia Suicide Rating Scale (C-SSRS): Suicidal Ideation, Behavior Scores and Intensity Scores
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Dental Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Late Neurotoxic Effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total Operative Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of eggs obtained
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Fugl-Meyer Upper Extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-term adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Time to Sleep Onset
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Vulnerable Elders Survey score (VES-13)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Muscle contraction - TOF twitch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving complete remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Statin toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Anti Clot Treatment Scale (ACTS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Qualitative assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in salivary volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Akathisia
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Were Treatment Failures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: B-mode ultrasound of carotid arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in incentive spirometry volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevalence of clinically-significant post-partum depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Subjects With Vaccine Response to Anti-glycoprotein E Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentrations of Antibodies Against Anti-gE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity of the tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive and negative predictive values (PV+ and PV-)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cognitive testing scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Efficacy of EK-12 compared to interferon beta-1a
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Per-patient success rates based on Sexual Encounter Profile, Question 3
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Change in Daily headache scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of gastrointestinal motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CT Scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RT-PCR results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of spontaneous social communication attempts
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: oscillatory abnormalities in resting and sensory response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects With 1 or More Culture-verified Acute VVC Episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute Change in Total Clinical Score (TCS) of Clinical Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of catheter occlusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tibiofibular distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing time of donor site wound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Concordance of HostDx Sepsis diagnostic test read-out: likelihood of bacterial infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Concordance of HostDx Sepsis diagnostic test read-out: likelihood of viral infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Concordance of HostDx Sepsis prognostic read-out (severity) with patient outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective response rate per RECIST v1.1 criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parasite Reduction Ratio (PRR48)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Hamilton Depression Rating Scale 17 (HDRS-17) Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Range of Motion (ROM) of cervical spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of negative appendectomies
Endpoint domain: Adverse events/effects
Primary endpoint: All-cause 90-day mortality
Endpoint domain: Mortality/survival
Primary endpoint: Wish for surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Target Lumen Revascularisation (TLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change from baseline on the S-TOPS pain symptom scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the Curve of algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quotient of Stimulated C-peptide/Glucose Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in functional respiratory imaging parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in lung function parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in standardized score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transcutaneous CO2 level in mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of colorectal cancer screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of Patients With Treatment Failure
Endpoint domain: Adverse events/effects
Primary endpoint: Cortisol Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage reduction on Impulsivity Rating Scale (IRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief of endometriosis-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overactive Bladder Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protective Anti-HBs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 28-day mortality from all causes
Endpoint domain: Mortality/survival
Primary endpoint: Body mass index changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of red blood cell concentrates received
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of platelet concentrates received
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of plasma units received
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: cTnI concentration at 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hospital Anxiety And Depression Scale (HADS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Degree of transient cognitive changes postoperatively
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Death or Neurologic Disability
Endpoint domain: Mortality/survival
Primary endpoint: Ocular perfusion pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: ONH blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Subjects Reporting at Least 1 Treatment-emergent Adverse Event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Individual plasma concentrations of free and conjugated resveratrol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scale Agreement at Time Zero (VAS-100)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scale Agreement at Time Zero (NRS-11)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scale Agreement at Time One (VAS-100)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scale Agreement at Time One (NRS-11)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Heavy Drinking Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects With Drug-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Postoperative Short-Term Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Postoperative Long-Term Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients undergoing sleep study testing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Smoking Lapse Analogue Task (delay score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trier Social Stress Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urticaria Activity Score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Life Quality Index (DLQI) improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fluoropyrimidine-related toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: HPV prevalence of vaccine-type
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: End expiratory nasopharyngeal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Medical Abortion Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Repeat Pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Total Alcohol Consumption (TAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Heavy Drinking Days (HDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device and Procedural Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Asthma Exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in neurocognitive outcomes (oNCF z-score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in muscle cross-sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in anthropometric measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy density of the diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clean margin wide resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Modified Oswestry Disability Index (MODI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Scores on the Verbal Rating Scale For Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Camberwell Assessment of Need (CAN)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of superficial nodules detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in serum uromodulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Occurrence of agitation-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in peak subjective fear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in behavioral approach
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in heart rate reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes